Pharmaceutical Industry Articles & Reports - Page 34

Learn about the FDA's AI/ML medical device tracker. With 1,451 devices authorized through 2025 and 295 cleared in 2025 alone, we analyze authorization trends, specialty breakdown, foundation model milestones, and the evolving regulatory framework

What is a TPA? Learn the role of Third-Party Administrators in self-funded health insurance, from claims processing and plan administration to cost containment. Updated with 2026 regulatory reforms including the CAA 2026 and DOL transparency rules.

An in-depth analysis of the Swiss healthcare system (updated March 2026). Covers the EFAS reform, TARDOC tariff, EPR overhaul, rising premiums, and the unique decentralized model of mandatory insurance (LAMal/KVG).

McKesson, Cencora, and Cardinal Health control over 90% of US drug distribution ($900B+ combined revenue). Full market analysis with FY2025 financials and 2025-2026 developments.

Explore the top 3 PBMs controlling 80% of the U.S. market. Updated with 2026 federal reform law, FTC Express Scripts settlement, DOJ UnitedHealth probe, and landmark rebate pass-through requirements.

An in-depth analysis of the leaders in pharma digital transformation, examining the strategies of companies like AstraZeneca, Roche, Pfizer, Eli Lilly, and Sanofi with AI, generative AI, and cloud technologies — updated with 2025-2026 developments including Lilly's $1B NVIDIA AI lab and FDA AI guidance.

Get a detailed guide to Oracle Life Sciences solutions. Learn about key products for clinical trials (Clinical One 26.1), pharmacovigilance (Argus Safety), Health Data Intelligence, and AI-powered analytics.

An in-depth guide to Veeva Vault. Learn how this cloud platform for life sciences manages regulated content, ensures GxP compliance, and unifies data management

A research-based guide to healthcare chatbot platforms (updated March 2026). Compare AI solutions for patient engagement, symptom triage, and HIPAA compliance including Hippocratic AI, Ada Health, Microsoft Healthcare Agent Service, and more.

Learn key principles for custom pharmaceutical software app design. Updated for 2026 with FDA CSA guidance, GAMP 5 Second Edition, GxP compliance, 21 CFR Part 11, and AI/ML trends

Learn about SMART on FHIR for EHR interoperability. This guide covers the FHIR Coverage resource, CDS Hooks, TEFCA, Da Vinci IGs, and the latest 2025-2026 regulatory updates for building modern healthcare applications.

Learn the essential HIPAA compliance requirements for healthcare startups. This updated 2026 guide compares SOC 2 and HITRUST to help you choose the right framework for PHI protection, with the latest breach statistics, enforcement actions, and regulatory developments.

Updated 2026 guide to Medicare Part D vs. Medicare Advantage drug plans, including IRA drug price negotiations, $2,000 OOP cap, and Medicaid managed care changes under the 2025 reconciliation law.

Learn how the NCPDP SCRIPT standard enables electronic prior authorization (ePA). Explore the technical workflow, Surescripts CompletEPA, CMS-0057-F requirements, AI automation, and FHIR-based PA APIs shaping 2026-2028 compliance.

Learn the key differences between NDC and RxNorm drug coding systems. Updated for 2026 with FDA's finalized 12-digit NDC rule, HCPCS J-code updates, and RxNorm developments.

Learn what Pharmacy Benefit Managers (PBMs) are and their role in the U.S. healthcare system. Updated for 2026 with FTC Express Scripts settlement, CAA 2026 federal PBM reform, Medicare Part D changes, and latest state regulations.

Learn about X12 EDI integration for startups (updated March 2026). This guide compares top vendors and solutions, from traditional VANs to modern cloud EDI-as-a-Service platforms with AI-powered capabilities.

Learn the key differences between pharmacy vs. medical benefit and how this structure impacts insurance coverage for GLP-1 drugs for diabetes and obesity, including the 2025–2026 Medicare BALANCE Model, manufacturer price cuts, and employer coverage trends.

Learn what drug formulary tiers are and how they affect prescription costs. Updated for 2026 with CMS-0057-F ePA rules, gold card laws, and IRA drug cost caps.

Learn how PBMs work and compare self-funded vs. fully insured health plans. Updated for 2026 with FTC settlement, federal rebate pass-through mandate, and latest KFF data on financing models, ERISA, risk, and PBM impact on drug costs.

A deep-dive tutorial on the EDI X12 270/271 transaction sets. Learn how this HIPAA standard enables real-time pharmacy benefit and eligibility verification, updated with 2025 Surescripts data, CMS-0057-F FHIR mandates, and NCPDP RTPB v13 requirements.

Compare the top 5 Availity alternatives for healthcare claims management in 2026. Covers Waystar (post-IPO), TriZetto (data breach impact), Experian Health, Office Ally, and SSI Group with updated KLAS rankings and market data.

Learn the technical structure of the ANSI ASC X12 EDI format. This guide explains B2B data exchange via envelopes (ISA/IEA), segments, data elements, and delimi

An educational analysis of Nirvana Health's history, its evolution from PBM RxAdvance, and its Aria platform for automating payer and PBM operations with AI, RPA, and the 2025 Transaction-as-a-Service (TaaS) model